These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 34174550)

  • 1. Sensitivity and specificity of the CRAFFT to identify heavy cannabis use: Evidence from a large statewide adolescent sample.
    Lee CA; Smith DC; Lanker A; Clary KL
    Addict Behav; 2021 Nov; 122():107006. PubMed ID: 34174550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The CRAFFT cut-points and DSM-5 criteria for alcohol and other drugs: a reevaluation and reexamination.
    Mitchell SG; Kelly SM; Gryczynski J; Myers CP; O'Grady KE; Kirk AS; Schwartz RP
    Subst Abus; 2014; 35(4):376-80. PubMed ID: 25036144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validity of the CRAFFT substance abuse screening test among adolescent clinic patients.
    Knight JR; Sherritt L; Shrier LA; Harris SK; Chang G
    Arch Pediatr Adolesc Med; 2002 Jun; 156(6):607-14. PubMed ID: 12038895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alcohol screening in young persons attending a sexually transmitted disease clinic. Comparison of AUDIT, CRAFFT, and CAGE instruments.
    Cook RL; Chung T; Kelly TM; Clark DB
    J Gen Intern Med; 2005 Jan; 20(1):1-6. PubMed ID: 15693920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation and performance of the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) among adolescent primary care patients.
    Gryczynski J; Kelly SM; Mitchell SG; Kirk A; O'Grady KE; Schwartz RP
    Addiction; 2015 Feb; 110(2):240-7. PubMed ID: 25311148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validity of the CRAFFT in American-Indian and Alaska-Native adolescents: screening for drug and alcohol risk.
    Cummins LH; Chan KK; Burns KM; Blume AW; Larimer M; Marlatt GA
    J Stud Alcohol; 2003 Sep; 64(5):727-32. PubMed ID: 14572196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychometric properties and concurrent validity of the CRAFFT among Norwegian adolescents. Ung@hordaland, a population-based study.
    Skogen JC; Bøe T; Knudsen AK; Hysing M
    Addict Behav; 2013 Oct; 38(10):2500-5. PubMed ID: 23770648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of CRAFFT for Use in Youth Correctional Institutions in Lagos, Nigeria.
    Ola B; Atilola O
    J Am Acad Psychiatry Law; 2017 Dec; 45(4):439-446. PubMed ID: 29282234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of the Brazilian version of the CRAFFT/CESARE scale for screening drug use by adolescents].
    Pereira BA; Schram PF; Azevedo RC
    Cien Saude Colet; 2016 Jan; 21(1):91-9. PubMed ID: 26816167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accuracy of five self-report screening instruments for substance use in pregnancy.
    Ondersma SJ; Chang G; Blake-Lamb T; Gilstad-Hayden K; Orav J; Beatty JR; Goyert GL; Yonkers KA
    Addiction; 2019 Sep; 114(9):1683-1693. PubMed ID: 31216102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of the psychometric properties of the CRAFFT instrument: 1999-2010.
    Dhalla S; Zumbo BD; Poole G
    Curr Drug Abuse Rev; 2011 Mar; 4(1):57-64. PubMed ID: 21466499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening and brief intervention for alcohol and other abuse.
    Harris SK; Louis-Jacques J; Knight JR
    Adolesc Med State Art Rev; 2014 Apr; 25(1):126-56. PubMed ID: 25022191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive Validity of the CRAFFT for Substance Use Disorder.
    Shenoi RP; Linakis JG; Bromberg JR; Casper TC; Richards R; Mello MJ; Chun TH; Spirito A;
    Pediatrics; 2019 Aug; 144(2):. PubMed ID: 31341007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychometric properties and operating characteristics of the Spanish-adapted version of the CRAFFT questionnaire in adolescents from Greater Buenos Aires.
    Colica D; Campana V; Vázquez Peña FR; Barán Cegla P; Viettoa V
    Arch Argent Pediatr; 2019 Oct; 117(5):301-305. PubMed ID: 31560485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening in Primary Care: What Is the Best Way to Identify At-Risk Youth for Substance Use?
    D'Amico EJ; Parast L; Meredith LS; Ewing BA; Shadel WG; Stein BD
    Pediatrics; 2016 Dec; 138(6):. PubMed ID: 27940696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Empirical validation of the CRAFFT Abuse Screening Test in a Spanish sample.
    Rial A; Kim-Harris S; Knight JR; Araujo M; Gómez P; Braña T; Varela J; Golpe S
    Adicciones; 2019 Apr; 31(2):160-169. PubMed ID: 29353300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychometric Properties of the AUDIT, AUDIT-C, CRAFFT and ASSIST-Y among Swedish Adolescents.
    Källmén H; Berman AH; Jayaram-Lindström N; Hammarberg A; Elgán TH
    Eur Addict Res; 2019; 25(2):68-77. PubMed ID: 30726842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcultural adaptation and validation of the CRAFFT as a screening test for problematic alcohol and substance use, abuse and dependence in a group of Argentine adolescents.
    Bertini MC; Busaniche J; Baquero F; Eymann A; Krauss M; Paz M; Catsicaris C
    Arch Argent Pediatr; 2015 Apr; 113(2):114-8. PubMed ID: 25727823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validity of brief alcohol screening tests among adolescents: a comparison of the AUDIT, POSIT, CAGE, and CRAFFT.
    Knight JR; Sherritt L; Harris SK; Gates EC; Chang G
    Alcohol Clin Exp Res; 2003 Jan; 27(1):67-73. PubMed ID: 12544008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Determination of the concurrent validity of the CRAFT-d - a screening instrument for problematic alcohol consumption].
    Tossmann P; Kasten L; Lang P; Strüber E
    Z Kinder Jugendpsychiatr Psychother; 2009 Sep; 37(5):451-9. PubMed ID: 19739063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.